Global HIV Vaccines Market Growth (Status and Outlook) 2022-2028
- LP 4809330
- 86 Pages
- February 2022
- Pharmaceuticals
The United States HIV Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global HIV Vaccines market, reaching US$ million by the year 2028. As for the Europe HIV Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main HIV Vaccines players cover Argos Therapeutics, Bionor Pharma, Janssen Global Services, and Genecure, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Vaccines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Phase I
Phase II
Phase III
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Research Institute
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Argos Therapeutics
Bionor Pharma
Janssen Global Services
Genecure
Geovax
Paxvax
Inovio Pharmaceuticals
Glaxosmithkline
Sanofi
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HIV Vaccines Market Size 2017-2028
2.1.2 HIV Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 HIV Vaccines Segment by Type
2.2.1 Phase I
2.2.2 Phase II
2.2.3 Phase III
2.3 HIV Vaccines Market Size by Type
2.3.1 HIV Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global HIV Vaccines Market Size Market Share by Type (2017-2022)
2.4 HIV Vaccines Segment by Application
2.4.1 Research Institute
2.4.2 Others
2.5 HIV Vaccines Market Size by Application
2.5.1 HIV Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global HIV Vaccines Market Size Market Share by Application (2017-2022)
3 HIV Vaccines Market Size by Player
3.1 HIV Vaccines Market Size Market Share by Players
3.1.1 Global HIV Vaccines Revenue by Players (2020-2022)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global HIV Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV Vaccines by Regions
4.1 HIV Vaccines Market Size by Regions (2017-2022)
4.2 Americas HIV Vaccines Market Size Growth (2017-2022)
4.3 APAC HIV Vaccines Market Size Growth (2017-2022)
4.4 Europe HIV Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa HIV Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas HIV Vaccines Market Size by Country (2017-2022)
5.2 Americas HIV Vaccines Market Size by Type (2017-2022)
5.3 Americas HIV Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Vaccines Market Size by Region (2017-2022)
6.2 APAC HIV Vaccines Market Size by Type (2017-2022)
6.3 APAC HIV Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe HIV Vaccines by Country (2017-2022)
7.2 Europe HIV Vaccines Market Size by Type (2017-2022)
7.3 Europe HIV Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HIV Vaccines by Region (2017-2022)
8.2 Middle East & Africa HIV Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa HIV Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global HIV Vaccines Market Forecast
10.1 Global HIV Vaccines Forecast by Regions (2023-2028)
10.1.1 Global HIV Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas HIV Vaccines Forecast
10.1.3 APAC HIV Vaccines Forecast
10.1.4 Europe HIV Vaccines Forecast
10.1.5 Middle East & Africa HIV Vaccines Forecast
10.2 Americas HIV Vaccines Forecast by Country (2023-2028)
10.2.1 United States HIV Vaccines Market Forecast
10.2.2 Canada HIV Vaccines Market Forecast
10.2.3 Mexico HIV Vaccines Market Forecast
10.2.4 Brazil HIV Vaccines Market Forecast
10.3 APAC HIV Vaccines Forecast by Region (2023-2028)
10.3.1 China HIV Vaccines Market Forecast
10.3.2 Japan HIV Vaccines Market Forecast
10.3.3 Korea HIV Vaccines Market Forecast
10.3.4 Southeast Asia HIV Vaccines Market Forecast
10.3.5 India HIV Vaccines Market Forecast
10.3.6 Australia HIV Vaccines Market Forecast
10.4 Europe HIV Vaccines Forecast by Country (2023-2028)
10.4.1 Germany HIV Vaccines Market Forecast
10.4.2 France HIV Vaccines Market Forecast
10.4.3 UK HIV Vaccines Market Forecast
10.4.4 Italy HIV Vaccines Market Forecast
10.4.5 Russia HIV Vaccines Market Forecast
10.5 Middle East & Africa HIV Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt HIV Vaccines Market Forecast
10.5.2 South Africa HIV Vaccines Market Forecast
10.5.3 Israel HIV Vaccines Market Forecast
10.5.4 Turkey HIV Vaccines Market Forecast
10.5.5 GCC Countries HIV Vaccines Market Forecast
10.6 Global HIV Vaccines Forecast by Type (2023-2028)
10.7 Global HIV Vaccines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Information
11.1.2 Argos Therapeutics HIV Vaccines Product Offered
11.1.3 Argos Therapeutics HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Argos Therapeutics Main Business Overview
11.1.5 Argos Therapeutics Latest Developments
11.2 Bionor Pharma
11.2.1 Bionor Pharma Company Information
11.2.2 Bionor Pharma HIV Vaccines Product Offered
11.2.3 Bionor Pharma HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bionor Pharma Main Business Overview
11.2.5 Bionor Pharma Latest Developments
11.3 Janssen Global Services
11.3.1 Janssen Global Services Company Information
11.3.2 Janssen Global Services HIV Vaccines Product Offered
11.3.3 Janssen Global Services HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Janssen Global Services Main Business Overview
11.3.5 Janssen Global Services Latest Developments
11.4 Genecure
11.4.1 Genecure Company Information
11.4.2 Genecure HIV Vaccines Product Offered
11.4.3 Genecure HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Genecure Main Business Overview
11.4.5 Genecure Latest Developments
11.5 Geovax
11.5.1 Geovax Company Information
11.5.2 Geovax HIV Vaccines Product Offered
11.5.3 Geovax HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Geovax Main Business Overview
11.5.5 Geovax Latest Developments
11.6 Paxvax
11.6.1 Paxvax Company Information
11.6.2 Paxvax HIV Vaccines Product Offered
11.6.3 Paxvax HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Paxvax Main Business Overview
11.6.5 Paxvax Latest Developments
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Information
11.7.2 Inovio Pharmaceuticals HIV Vaccines Product Offered
11.7.3 Inovio Pharmaceuticals HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Inovio Pharmaceuticals Main Business Overview
11.7.5 Inovio Pharmaceuticals Latest Developments
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Company Information
11.8.2 Glaxosmithkline HIV Vaccines Product Offered
11.8.3 Glaxosmithkline HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Glaxosmithkline Main Business Overview
11.8.5 Glaxosmithkline Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi HIV Vaccines Product Offered
11.9.3 Sanofi HIV Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
12 Research Findings and Conclusion
Table 1. HIV Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Phase I
Table 3. Major Players of Phase II
Table 4. Major Players of Phase III
Table 5. HIV Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global HIV Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global HIV Vaccines Market Size Market Share by Type (2017-2022)
Table 8. HIV Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global HIV Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global HIV Vaccines Market Size Market Share by Application (2017-2022)
Table 11. Global HIV Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global HIV Vaccines Revenue Market Share by Player (2020-2022)
Table 13. HIV Vaccines Key Players Head office and Products Offered
Table 14. HIV Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HIV Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global HIV Vaccines Market Size Market Share by Regions (2017-2022)
Table 19. Americas HIV Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas HIV Vaccines Market Size Market Share by Country (2017-2022)
Table 21. Americas HIV Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas HIV Vaccines Market Size Market Share by Type (2017-2022)
Table 23. Americas HIV Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas HIV Vaccines Market Size Market Share by Application (2017-2022)
Table 25. APAC HIV Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC HIV Vaccines Market Size Market Share by Region (2017-2022)
Table 27. APAC HIV Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC HIV Vaccines Market Size Market Share by Type (2017-2022)
Table 29. APAC HIV Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC HIV Vaccines Market Size Market Share by Application (2017-2022)
Table 31. Europe HIV Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe HIV Vaccines Market Size Market Share by Country (2017-2022)
Table 33. Europe HIV Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe HIV Vaccines Market Size Market Share by Type (2017-2022)
Table 35. Europe HIV Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe HIV Vaccines Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa HIV Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa HIV Vaccines Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa HIV Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa HIV Vaccines Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa HIV Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa HIV Vaccines Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of HIV Vaccines
Table 44. Key Market Challenges & Risks of HIV Vaccines
Table 45. Key Industry Trends of HIV Vaccines
Table 46. Global HIV Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global HIV Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global HIV Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global HIV Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global HIV Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global HIV Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 52. Argos Therapeutics Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 53. Argos Therapeutics HIV Vaccines Product Offered
Table 54. Argos Therapeutics HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Argos Therapeutics Main Business
Table 56. Argos Therapeutics Latest Developments
Table 57. Bionor Pharma Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 58. Bionor Pharma HIV Vaccines Product Offered
Table 59. Bionor Pharma Main Business
Table 60. Bionor Pharma HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bionor Pharma Latest Developments
Table 62. Janssen Global Services Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 63. Janssen Global Services HIV Vaccines Product Offered
Table 64. Janssen Global Services Main Business
Table 65. Janssen Global Services HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Janssen Global Services Latest Developments
Table 67. Genecure Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 68. Genecure HIV Vaccines Product Offered
Table 69. Genecure Main Business
Table 70. Genecure HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Genecure Latest Developments
Table 72. Geovax Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 73. Geovax HIV Vaccines Product Offered
Table 74. Geovax Main Business
Table 75. Geovax HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Geovax Latest Developments
Table 77. Paxvax Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 78. Paxvax HIV Vaccines Product Offered
Table 79. Paxvax Main Business
Table 80. Paxvax HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Paxvax Latest Developments
Table 82. Inovio Pharmaceuticals Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 83. Inovio Pharmaceuticals HIV Vaccines Product Offered
Table 84. Inovio Pharmaceuticals Main Business
Table 85. Inovio Pharmaceuticals HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Inovio Pharmaceuticals Latest Developments
Table 87. Glaxosmithkline Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 88. Glaxosmithkline HIV Vaccines Product Offered
Table 89. Glaxosmithkline Main Business
Table 90. Glaxosmithkline HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Glaxosmithkline Latest Developments
Table 92. Sanofi Details, Company Type, HIV Vaccines Area Served and Its Competitors
Table 93. Sanofi HIV Vaccines Product Offered
Table 94. Sanofi Main Business
Table 95. Sanofi HIV Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Sanofi Latest Developments
List of Figures
Figure 1. HIV Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global HIV Vaccines Market Size Market Share by Type in 2021
Figure 7. HIV Vaccines in Research Institute
Figure 8. Global HIV Vaccines Market: Research Institute (2017-2022) & ($ Millions)
Figure 9. HIV Vaccines in Others
Figure 10. Global HIV Vaccines Market: Others (2017-2022) & ($ Millions)
Figure 11. Global HIV Vaccines Market Size Market Share by Application in 2021
Figure 12. Global HIV Vaccines Revenue Market Share by Player in 2021
Figure 13. Global HIV Vaccines Market Size Market Share by Regions (2017-2022)
Figure 14. Americas HIV Vaccines Market Size 2017-2022 ($ Millions)
Figure 15. APAC HIV Vaccines Market Size 2017-2022 ($ Millions)
Figure 16. Europe HIV Vaccines Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa HIV Vaccines Market Size 2017-2022 ($ Millions)
Figure 18. Americas HIV Vaccines Value Market Share by Country in 2021
Figure 19. Americas HIV Vaccines Consumption Market Share by Type in 2021
Figure 20. Americas HIV Vaccines Market Size Market Share by Application in 2021
Figure 21. United States HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC HIV Vaccines Market Size Market Share by Region in 2021
Figure 26. APAC HIV Vaccines Market Size Market Share by Application in 2021
Figure 27. China HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 31. India HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe HIV Vaccines Market Size Market Share by Country in 2021
Figure 34. Europe HIV Vaccines Market Size Market Share by Type in 2021
Figure 35. Europe HIV Vaccines Market Size Market Share by Application in 2021
Figure 36. Germany HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 37. France HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa HIV Vaccines Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa HIV Vaccines Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa HIV Vaccines Market Size Market Share by Application in 2021
Figure 44. Egypt HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country HIV Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 50. APAC HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 51. Europe HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 53. United States HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 54. Canada HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 55. Mexico HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 56. Brazil HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 57. China HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 58. Japan HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 59. Korea HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. India HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Australia HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. Germany HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. France HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. UK HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. Italy HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. Russia HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. Spain HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. Egypt HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. South Africa HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. Israel HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. Turkey HIV Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries HIV Vaccines Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
